Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma

By sjmartinez • March 14, 2023

Corren J, Wechsler ME, Chupp G, Roseti SL, Hellqvist Å, Martin N, Llanos JP, Ambrose CS, Colice G. Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma. J Allergy Clin Immunol Pract. 2023 Mar;11(3):943-945.e2. doi: 10.1016/j.jaip.2022.10.042. Epub 2022 Nov 11. PMID: 36375743.

Tags: Allergy & Immunology, Publications

From Mild to Mayhem: A Life-Threatening Exacerbation of Mild Asthma

Brown K, Anderson L. From Mild to Mayhem: A Life-Threatening Exacerbation of Mild Asthma. Cureus. 2024 Sep 30;16(9):e70558. doi: 10.7759/cureus.70558. PMID: 39479137; PMCID: PMC11524714.

Psychosocial issues and quality of life associated with food allergy

Kachru R. Psychosocial issues and quality of life associated with food allergy. J Food Allergy. 2024 Jul 8;2(1):95-98. doi: 10.2500/jfa.2020.2.200025. PMID: 39022158; PMCID: PMC11250222.

Dupilumab Reduces Exacerbations Independent of Changes in Biomarkers in Moderate-to-Severe Asthma

Pavord ID, Casale TB, Corren J, FitzGerald MJ, Deniz Y, Altincatal A, Gall R, Pandit-Abid N, Radwan A, Jacob-Nara JA, Rowe PJ, Busse WW. Dupilumab[...]